Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Endocrine 2Thoracic 1Breast 1

Conditions

Breast Neoplasms 182Triple Negative Breast Neoplasms 24Lung Neoplasms 16Ovarian Neoplasms 11Melanoma 11Prostatic Neoplasms 10Pancreatic Neoplasms 10Colonic Neoplasms 10Sarcoma 9Neoplasms 8Stomach Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Uterine Cervical Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Brain Neoplasms 4Small Cell Lung Carcinoma 3Liver Neoplasms 3Kidney Neoplasms 3Endometrial Neoplasms 3Carcinoma, Lobular 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Adrenal Gland Neoplasms × Breast × Clear all
NCT01086696 2019-12-17

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
6 enrolled
BreastEndocrineGenitourinaryThoracic

Adrenal Gland Neoplasms, Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡